7,031 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Focus Partners Wealth

Focus Partners Wealth bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 7,031 shares of the company's stock, valued at approximately $649,000.

Other large investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB boosted its holdings in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares in the last quarter. Colonial Trust Co SC purchased a new position in Encompass Health during the 4th quarter worth approximately $29,000. Transce3nd LLC purchased a new position in Encompass Health during the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Finally, V Square Quantitative Management LLC grew its position in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares in the company, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Encompass Health Trading Up 0.2%

Shares of NYSE:EHC opened at $121.15 on Tuesday. The firm has a fifty day moving average of $105.97 and a two-hundred day moving average of $100.90. The firm has a market capitalization of $12.21 billion, a P/E ratio of 27.16, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $121.44. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter last year, the business posted $1.12 EPS. On average, equities analysts expect that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. Encompass Health's dividend payout ratio is currently 14.05%.

Analyst Ratings Changes

Several equities analysts have weighed in on EHC shares. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Sunday, May 11th. Barclays lifted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. UBS Group lifted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Royal Bank of Canada lifted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Finally, William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $120.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.